Pfizer buying FoldRx for undisclosed amount
NEW YORK - Pfizer says it will buy privately held FoldRx Pharmaceuticals for an undisclosed amount, expanding its pipeline of potential products.
Chipmaker Standard Microsystems Corp. is folding in a brief contest to acquire Newport Beach-based Conexant Systems Inc., which now appears set to sell for $303 million to a San Francisco private equity firm.